Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Valero Energy
VLO
$86.5B
| $104M | 0.07% |
912,617
-22,728
| -2% | -$2.58M |
|
202
Cigna
CI
$74B
| $104M | 0.07% |
498,258
+24,106
| +5% | +$4.47M |
|
203
Intuitive Surgical
ISRG
$133B
| $103M | 0.07% |
538,359
+128,859
| +31% | +$22.9M |
|
204
Eaton
ETN
$175B
| $103M | 0.07% |
1,183,399
+48,637
| +4% | +$3.98M |
|
205
CALL
Marvell Technology
MRVL
$194B
| $100M | 0.07% |
5,186,440
+4,835,540
| +1,378% | +$99.4M |
|
206
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$147M
| $99.3M | 0.07% |
58,125
| – | – |
|
207
Viatris
VTRS
$19.4B
| $99.2M | 0.07% |
2,711,613
+1,405,347
| +108% | +$52.8M |
|
208
PUT
Chipotle Mexican Grill
CMG
$41.9B
| $98.9M | 0.07% |
10,880,000
+4,010,000
| +58% | +$38.1M |
|
209
Zimmer Biomet
ZBH
$18.3B
| $98.8M | 0.07% |
774,449
+46,266
| +6% | +$5.5M |
|
210
Advanced Micro Devices
AMD
$787B
| $98.8M | 0.07% |
3,199,337
+1,406,980
| +78% | +$31.8M |
|
211
PUT
JPMorgan Chase
JPM
$947B
| $98.4M | 0.07% |
872,200
+341,100
| +64% | +$38.7M |
|
212
CALL
Citigroup
C
$226B
| $98.3M | 0.07% |
1,370,600
+247,400
| +22% | +$17.5M |
|
213
Duke Energy
DUK
$97.1B
| $98.3M | 0.07% |
1,228,410
+246,387
| +25% | +$19.9M |
|
214
Illumina
ILMN
$29B
| $97.3M | 0.07% |
272,456
+40,159
| +17% | +$12.9M |
|
215
CME Group
CME
$95.5B
| $97.3M | 0.07% |
571,430
+136,168
| +31% | +$22.9M |
|
216
Northrop Grumman
NOC
$80.2B
| $97.1M | 0.07% |
305,947
+68,311
| +29% | +$20.8M |
|
217
Xcel Energy
XEL
$48.6B
| $96.7M | 0.07% |
2,048,269
+625,369
| +44% | +$29.5M |
|
218
NextEra Energy
NEE
$177B
| $96.3M | 0.07% |
2,297,248
-1,758,248
| -43% | -$74.8M |
|
219
Becton Dickinson
BDX
$48.3B
| $95.2M | 0.07% |
373,821
+36,450
| +11% | +$8.98M |
|
220
Truist Financial
TFC
$64B
| $94.3M | 0.07% |
1,942,587
+653,600
| +51% | +$33.5M |
|
|
AGN
221
PUT
DELISTED
Allergan plc
AGN
| $94.2M | 0.07% |
494,700
-253,600
| -34% | -$46.6M |
|
222
Public Storage
PSA
$61.3B
| $93.9M | 0.07% |
465,676
+142,292
| +44% | +$30.7M |
|
223
SPDR Gold Trust
GLD
$141B
| $93.8M | 0.07% |
832,054
-181,208
| -18% | -$20.8M |
|
224
Automatic Data Processing
ADP
$108B
| $93.6M | 0.06% |
620,949
+89,164
| +17% | +$12.6M |
|
225
PUT
Biogen
BIIB
$30.3B
| $92.2M | 0.06% |
261,000
+66,400
| +34% | +$22.9M |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.